bluuebunny/crossref_metadata_2025 huggingface dataset:
Table S1 from Safety, Antitumor Activity, and T-cell Responses in a Dose-Ranging Phase I Trial of the Oncolytic Peptide LTX-315 in Patients with Solid Tumors
Authors: Spicer James , Marabelle Aurélien , Baurain Jean-Francois , Jebsen Nina Louise , Jøssang Dag Erik , Awada Ahmad , Kristeleit Rebecca , Loirat Delphine , Lazaridis George , Jungels Christiane , Brunsvig Paal , Nicolaisen Berit , Saunders Andrew , Patel Hamina , Galon Jérôme , Hermitte Fabienne , Camilio Ketil André , Mauseth Brynjar , Sundvold Vibeke , Sveinbjørnsson Baldur , Rekdal Øystein
Published: April 2023

Table S1 shows dosing schedule and drug-related treatment-emergent adverse events occurring in at least 10% of patients in this study.
Supplementary Figure 7 from Effects of HER Family–targeting Tyrosine Kinase Inhibitors on Antibody-dependent Cell-mediated Cytotoxicity in HER2-expressing Breast Cancer
Authors: Collins Denis M. , Madden Stephen F. , Gaynor Nicola , AlSultan Dalal , Le Gal Marion , Eustace Alex J. , Gately Kathy A. , Hughes Clare , Davies Anthony M. , Mahgoub Thamir , Ballot Jo , Toomey Sinead , O'Connor Darran P. , Gallagher William M. , Holmes Frankie A. , Espina Virginia , Liotta Lance , Hennessy Bryan T. , O'Byrne Kenneth J. , Hasmann Max , Bossenmaier Birgit , O'Donovan Norma , Crown John
Published: April 2023

Densitometry analysis for Figure 6B
Table S5 from Investigation of Antigen-Specific T-Cell Receptor Clusters in Human Cancers
Authors: Zhang Hongyi , Liu Longchao , Zhang Jian , Chen Jiahui , Ye Jianfeng , Shukla Sachet , Qiao Jian , Zhan Xiaowei , Chen Hao , Wu Catherine J. , Fu Yang-Xin , Li Bo
Published: April 2023

HLA genotypes information for samples with TSSK2 expression.
Supplementary Table 1 from Response to Standard Therapies and Comprehensive Genomic Analysis for Patients with Lung Adenocarcinoma with EGFR Exon 20 Insertions
Authors: Choudhury Noura J. , Schoenfeld Adam J. , Flynn Jessica , Falcon Christina J. , Rizvi Hira , Rudin Charles M. , Kris Mark G. , Arcila Maria E. , Heller Glenn , Yu Helena A. , Ladanyi Marc , Riely Gregory J.
Published: April 2023

Patient treatment details
Figure S2 from Integrative Genomic Analysis of Gemcitabine Resistance in Pancreatic Cancer by Patient-derived Xenograft Models
Authors: Yang Gang , Guan Wenfang , Cao Zhe , Guo Wenbo , Xiong Guangbing , Zhao Fangyu , Feng Mengyu , Qiu Jiangdong , Liu Yueze , Zhang Michael Q. , You Lei , Zhang Taiping , Zhao Yupei , Gu Jin
Published: April 2023

The TGI% of 66 PDXs during gemcitabine treatment
Figure from Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma: A Single-arm Phase II Feasibility Trial (PERFECT)
Authors: van den Ende Tom , de Clercq Nicolien C. , van Berge Henegouwen Mark I. , Gisbertz Suzanne S. , Geijsen E.D. , Verhoeven R.H.A. , Meijer Sybren L. , Schokker Sandor , Dings M.P.G. , Bergman Jacques J.G.H.M. , Haj Mohammad Nadia , Ruurda Jelle P. , van Hillegersberg Richard , Mook Stella , Nieuwdorp Max , de Gruijl Tanja D. , Soeratram Tanya T.D. , Ylstra Bauke , van Grieken Nicole C.T. , Bijlsma Maarten F. , Hulshof Maarten C.C.M. , van Laarhoven H.W.M.
Published: April 2023

Figure S3. FOXP3 evaluated on-treatment.
Supplementary Table from MAPK Pathway Alterations Correlate with Poor Survival and Drive Resistance to Therapy in Patients with Lung Cancers Driven by ROS1 Fusions
Authors: Sato Hiroki , Schoenfeld Adam J. , Siau Evan , Lu Yue Christine , Tai Huichun , Suzawa Ken , Kubota Daisuke , Lui Allan J.W. , Qeriqi Besnik , Mattar Marissa , Offin Michael , Sakaguchi Masakiyo , Toyooka Shinichi , Drilon Alexander , Rosen Neal X. , Kris Mark G. , Solit David , De Stanchina Elisa , Davare Monika A. , Riely Gregory J. , Ladanyi Marc , Somwar Romel
Published: April 2023

Supplementary tables are included.
Supplemental Appendix from Pan-Tumor Pathologic Scoring of Response to PD-(L)1 Blockade
Authors: Stein Julie E. , Lipson Evan J. , Cottrell Tricia R. , Forde Patrick M. , Anders Robert A. , Cimino-Mathews Ashley , Thompson Elizabeth D. , Allaf Mohamad E. , Yarchoan Mark , Feliciano Josephine , Wang Hao , Jaffee Elizabeth M. , Pardoll Drew M. , Topalian Suzanne L. , Taube Janis M.
Published: April 2023

Supplemental Appendix (Figures S1 and S2, Table S1)
Supplementary Figure S2 from Phase I Assessment of Safety and Therapeutic Activity of BAY1436032 in Patients with IDH1-Mutant Solid Tumors
Authors: Wick Antje , Bähr Oliver , Schuler Martin , Rohrberg Kristoffer , Chawla Sant P. , Janku Filip , Schiff David , Heinemann Volker , Narita Yoshitaka , Lenz Heinz-Josef , Ikeda Masafumi , Ando Yuichi , Wick Wolfgang , Steinbach Joachim P. , Burger Michael C. , Wenger Katharina , Lassen Ulrik , Sankhala Kamalesh K. , Roggia Cristiana , Genvresse Isabelle , Munhoz Catya , Rentzsch Christine , Reschke Susanne , Langer Simon , Wagner Markus , Kaulfuss Stefan , Cai Charles , Lagkadinou Eleni , Jeffers Michael , Peña Carol , Tabatabai Ghazaleh
Published: April 2023

Supplementary Figure S2. Tumor scans.
Supplementary Figure 2A from Efficacy and Safety of Duvelisib Following Disease Progression on Ofatumumab in Patients with Relapsed/Refractory CLL or SLL in the DUO Crossover Extension Study
Authors: Davids Matthew S. , Kuss Bryone J. , Hillmen Peter , Montillo Marco , Moreno Carol , Essell James , Lamanna Nicole , Nagy Zsolt , Tam Constantine S. , Stilgenbauer Stephan , Ghia Paolo , Delgado Julio , Lustgarten Stephanie , Weaver David T. , Youssoufian Hagop , Jäger Ulrich
Published: April 2023

Figure S2A displays probability of progression-free survival over time in subgroups of patients with and without del(11q)
Supplementary Data from Efficacy and Safety of Duvelisib Following Disease Progression on Ofatumumab in Patients with Relapsed/Refractory CLL or SLL in the DUO Crossover Extension Study
Authors: Davids Matthew S. , Kuss Bryone J. , Hillmen Peter , Montillo Marco , Moreno Carol , Essell James , Lamanna Nicole , Nagy Zsolt , Tam Constantine S. , Stilgenbauer Stephan , Ghia Paolo , Delgado Julio , Lustgarten Stephanie , Weaver David T. , Youssoufian Hagop , Jäger Ulrich
Published: April 2023

Supplemental Figure Legend
Supplementary Data from In Vivo Tracking of Adoptively Transferred Natural Killer Cells in Rhesus Macaques Using 89Zirconium-Oxine Cell Labeling and PET Imaging
Authors: Sato Noriko , Stringaris Kate , Davidson-Moncada Jan K. , Reger Robert , Adler Stephen S. , Dunbar Cynthia , Choyke Peter L. , Childs Richard W.
Published: April 2023

Supplementary Methods
Supplementary Data 1 from Diverse AR Gene Rearrangements Mediate Resistance to Androgen Receptor Inhibitors in Metastatic Prostate Cancer
Authors: Li Yingming , Yang Rendong , Henzler Christine M. , Ho Yeung , Passow Courtney , Auch Benjamin , Carreira Suzanne , Nava Rodrigues Daniel , Bertan Claudia , Hwang Tae Hyun , Quigley David A. , Dang Ha X. , Morrissey Colm , Fraser Michael , Plymate Stephen R. , Maher Christopher A. , Feng Felix Y. , de Bono Johann S. , Dehm Scott M.
Published: April 2023

Patients and Tissues
Figure S3 from A Somatostatin Receptor Subtype-3 (SST3) Peptide Agonist Shows Antitumor Effects in Experimental Models of Nonfunctioning Pituitary Tumors
Authors: Vázquez-Borrego Mari C. , Gupta Vandana , Ibáñez-Costa Alejandro , Gahete Manuel D. , Venegas-Moreno Eva , Toledano-Delgado Álvaro , Cano David A. , Blanco-Acevedo Cristóbal , Ortega-Salas Rosa , Japón Miguel A. , Barrera-Martín Ana , Vasiljevic Alexandre , Hill Jason , Zhang Shengwen , Halem Heather , Solivera Juan , Raverot Gérald , Gálvez María A. , Soto-Moreno Alfonso , Paez-Pereda Marcelo , Culler Michael D. , Castaño Justo P. , Luque Raúl M.
Published: April 2023

mRNA expression levels of SST3 in different pituitary neuroendocrine tumors (PitNETs) and NPs.
Supplementary Figures from Prognostic Significance of Blood-Based Multi-cancer Detection in Plasma Cell-Free DNA
Authors: Chen Xiaoji , Dong Zhao , Hubbell Earl , Kurtzman Kathryn N. , Oxnard Geoffrey R. , Venn Oliver , Melton Collin , Clarke Christina A. , Shaknovich Rita , Ma Ting , Meixiong Gerry , Seiden Michael V. , Klein Eric A. , Fung Eric T. , Liu Minetta C.
Published: April 2023

Supplementary Figures from Prognostic Significance of Blood-Based Multi-cancer Detection in Plasma Cell-Free DNA
Fig S7 from Inflammation Mediates the Development of Aggressive Breast Cancer Following Radiotherapy
Authors: Ma Lin , Gonzalez-Junca Alba , Zheng Yufei , Ouyang Haoxu , Illa-Bochaca Irineu , Horst Kathleen C. , Krings Gregor , Wang Yinghao , Fernandez-Garcia Ignacio , Chou William , Barcellos-Hoff Mary Helen
Published: April 2023

Supplementary Figure 7. Tumor growth raw and fitted curves from the aspirin mouse model.
Fig S6 from Inflammation Mediates the Development of Aggressive Breast Cancer Following Radiotherapy
Authors: Ma Lin , Gonzalez-Junca Alba , Zheng Yufei , Ouyang Haoxu , Illa-Bochaca Irineu , Horst Kathleen C. , Krings Gregor , Wang Yinghao , Fernandez-Garcia Ignacio , Chou William , Barcellos-Hoff Mary Helen
Published: April 2023

Supplementary Figure 6. Representative images of immune cells infiltration and proliferating cells.
Fig S5 from Inflammation Mediates the Development of Aggressive Breast Cancer Following Radiotherapy
Authors: Ma Lin , Gonzalez-Junca Alba , Zheng Yufei , Ouyang Haoxu , Illa-Bochaca Irineu , Horst Kathleen C. , Krings Gregor , Wang Yinghao , Fernandez-Garcia Ignacio , Chou William , Barcellos-Hoff Mary Helen
Published: April 2023

Supplementary Figure 5. Representative images of immune cells infiltration.
Fig S3 from Inflammation Mediates the Development of Aggressive Breast Cancer Following Radiotherapy
Authors: Ma Lin , Gonzalez-Junca Alba , Zheng Yufei , Ouyang Haoxu , Illa-Bochaca Irineu , Horst Kathleen C. , Krings Gregor , Wang Yinghao , Fernandez-Garcia Ignacio , Chou William , Barcellos-Hoff Mary Helen
Published: April 2023

Supplementary Figure 3 Macrophage differentiation from circulating human PBMC.
Figure S4 from CAR T cells Targeting Human Immunoglobulin Light Chains Eradicate Mature B-cell Malignancies While Sparing a Subset of Normal B Cells
Authors: Ranganathan Raghuveer , Shou Peishun , Ahn Sarah , Sun Chuang , West John , Savoldo Barbara , Dotti Gianpietro
Published: April 2023

Recurrent tumor cells in vivo
Fig S2 from Inflammation Mediates the Development of Aggressive Breast Cancer Following Radiotherapy
Authors: Ma Lin , Gonzalez-Junca Alba , Zheng Yufei , Ouyang Haoxu , Illa-Bochaca Irineu , Horst Kathleen C. , Krings Gregor , Wang Yinghao , Fernandez-Garcia Ignacio , Chou William , Barcellos-Hoff Mary Helen
Published: April 2023

Supplementary Figure 2. Tumor frequency and latency
Fig S1 from Inflammation Mediates the Development of Aggressive Breast Cancer Following Radiotherapy
Authors: Ma Lin , Gonzalez-Junca Alba , Zheng Yufei , Ouyang Haoxu , Illa-Bochaca Irineu , Horst Kathleen C. , Krings Gregor , Wang Yinghao , Fernandez-Garcia Ignacio , Chou William , Barcellos-Hoff Mary Helen
Published: April 2023

Supplementary Figure 1. Characteristics of sporadic and radiation-preceded breast cancer
Suppl Figure 4 from VLA4-Targeted Nanoparticles Hijack Cell Adhesion–Mediated Drug Resistance to Target Refractory Myeloma Cells and Prolong Survival
Authors: Fontana Francesca , Scott Michael J. , Allen John S. , Yang Xiaoxia , Cui Grace , Pan Dipanjan , Yanaba Noriko , Fiala Mark A. , O'Neal Julie , Schmieder-Atteberry Anne H. , Ritchey Julie , Rettig Michael , Simons Kathleen , Fletcher Steven , Vij Ravi , DiPersio John F. , Lanza Gregory M.
Published: April 2023

Supplemental figure 4 Color
Suppl Figure 3 from VLA4-Targeted Nanoparticles Hijack Cell Adhesion–Mediated Drug Resistance to Target Refractory Myeloma Cells and Prolong Survival
Authors: Fontana Francesca , Scott Michael J. , Allen John S. , Yang Xiaoxia , Cui Grace , Pan Dipanjan , Yanaba Noriko , Fiala Mark A. , O'Neal Julie , Schmieder-Atteberry Anne H. , Ritchey Julie , Rettig Michael , Simons Kathleen , Fletcher Steven , Vij Ravi , DiPersio John F. , Lanza Gregory M.
Published: April 2023

Supplemental Figure 3 Color
Table S4 from Phase II Single-arm Study of Durvalumab and Tremelimumab with Concurrent Radiotherapy in Patients with Mismatch Repair–proficient Metastatic Colorectal Cancer
Authors: Segal Neil H. , Cercek Andrea , Ku Geoffrey , Wu Abraham J. , Rimner Andreas , Khalil Danny N. , Reidy-Lagunes Diane , Cuaron John , Yang T. Jonathan , Weiser Martin R. , Romesser Paul B. , Stadler Zsofia K. , Varghese Anna M. , Ganesh Karuna , Yaeger Rona , Connell Louise C. , Faleck David , Abou-Alfa Ghassan K. , Mcauliffe Kathleen C. , Vaiskauskas Pamela , Solter Mark L. , Ogle Martinique , Adamow Matthew J. , Holland Aliya , Vedantam Pallavi , Wong Phillip , Merghoub Taha , Vakiani Efsevia , Hollmann Travis J. , Juluru Krishna , Chou Joanne F. , Capanu Marinela , Erinjeri Joseph , Solomon Stephen , Yamada Yoshiya , Kemeny Nancy , Crane Christopher H. , Saltz Leonard B.
Published: April 2023

Flow cytometry result summary
Supplementary fig 2 from Select Antitumor Cytotoxic CD8+ T Clonotypes Expand in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib
Authors: Baptista Maria Joao , Baskar Sivasubramanian , Gaglione Erika M. , Keyvanfar Keyvan , Ahn Inhye E. , Wiestner Adrian , Sun Clare
Published: April 2023

Scatter plot of the TRBV frequency as detected by next generation sequencing (NGS) and flow cytometry. Spearman rho correlation coefficient and two tail p-value are shown.
Supplementary fig 1 from Select Antitumor Cytotoxic CD8+ T Clonotypes Expand in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib
Authors: Baptista Maria Joao , Baskar Sivasubramanian , Gaglione Erika M. , Keyvanfar Keyvan , Ahn Inhye E. , Wiestner Adrian , Sun Clare
Published: April 2023

T cell counts at baseline, time of ibrutinib response, and progressive disease (PD). Individual values, median and interquartile range are shown. Dashed lines indicate the lower and upper limits of the normal reference range.
Supplementary Data from Modified RANO, Immunotherapy RANO, and Standard RANO Response to Convection-Enhanced Delivery of IL4R-Targeted Immunotoxin MDNA55 in Recurrent Glioblastoma
Authors: Ellingson Benjamin M. , Sampson John , Achrol Achal Singh , Aghi Manish K. , Bankiewicz Krystof , Wang Chencai , Bexon Martin , Brem Steven , Brenner Andrew , Chowdhary Sajeel , Floyd John R. , Han Seunggu , Kesari Santosh , Randazzo Dina , Vogelbaum Michael A. , Vrionis Frank , Zabek Miroslaw , Butowski Nicholas , Coello Melissa , Merchant Nina , Merchant Fahar
Published: April 2023

Supplemental Figure Captions
Supp Table 1 from Activity of Crizotinib in Patients with ALK-Aberrant Relapsed/Refractory Neuroblastoma: A Children's Oncology Group Study (ADVL0912)
Authors: Foster Jennifer H. , Voss Stephan D. , Hall David C. , Minard Charles G. , Balis Frank M. , Wilner Keith , Berg Stacey L. , Fox Elizabeth , Adamson Peter C. , Blaney Susan M. , Weigel Brenda J. , Mossé Yael P.
Published: April 2023

Supp Table 1
SupplementaryTables from Recurrent Human Papillomavirus–Related Head and Neck Cancer Undergoes Metabolic Reprogramming and Is Driven by Oxidative Phosphorylation
Authors: Vyas Avani , Harbison R. Alex , Faden Daniel L. , Kubik Mark , Palmer Drake , Zhang Qing , Osmanbeyoglu Hatice U. , Kiselyov Kirill , Méndez Eduardo , Duvvuri Umamaheswar
Published: April 2023

Supplemental Tables
Supplementary Tables from Role of Tumor-Infiltrating B Cells in Clinical Outcome of Patients with Melanoma Treated With Dabrafenib Plus Trametinib
Authors: Brase Jan C. , Walter Robert F.H. , Savchenko Alexander , Gusenleitner Daniel , Garrett James , Schimming Tobias , Varaljai Renata , Castelletti Deborah , Kim Ju , Dakappagari Naveen , Schultz Ken , Robert Caroline , Long Georgina V. , Nathan Paul D. , Ribas Antoni , Flaherty Keith T. , Karaszewska Boguslawa , Schachter Jacob , Sucker Antje , Schmid Kurt W. , Zimmer Lisa , Livingstone Elisabeth , Gasal Eduard , Schadendorf Dirk , Roesch Alexander
Published: April 2023

Supplementary Tables from Role of Tumor-Infiltrating B Cells in Clinical Outcome of Patients with Melanoma Treated With Dabrafenib Plus Trametinib
Supplementary Protocol from Deep Learning for Fully Automated Prediction of Overall Survival in Patients with Oropharyngeal Cancer Using FDG-PET Imaging
Authors: Cheng Nai-Ming , Yao Jiawen , Cai Jinzheng , Ye Xianghua , Zhao Shilin , Zhao Kui , Zhou Wenlan , Nogues Isabella , Huo Yuankai , Liao Chun-Ta , Wang Hung-Ming , Lin Chien-Yu , Lee Li-Yu , Xiao Jing , Lu Le , Zhang Ling , Yen Tzu-Chen
Published: April 2023

Supplementary Protocol
Figure S5 from Deep Learning for Fully Automated Prediction of Overall Survival in Patients with Oropharyngeal Cancer Using FDG-PET Imaging
Authors: Cheng Nai-Ming , Yao Jiawen , Cai Jinzheng , Ye Xianghua , Zhao Shilin , Zhao Kui , Zhou Wenlan , Nogues Isabella , Huo Yuankai , Liao Chun-Ta , Wang Hung-Ming , Lin Chien-Yu , Lee Li-Yu , Xiao Jing , Lu Le , Zhang Ling , Yen Tzu-Chen
Published: April 2023

KM analyses by HPV+ and cTNM, DeepPET-OPSCC risk category, entire cohort
Supplementary Figure S4 from Anti-CLL1 Chimeric Antigen Receptor T-Cell Therapy in Children with Relapsed/Refractory Acute Myeloid Leukemia
Authors: Zhang Hui , Wang Pengfei , Li Zhuoyan , He Yingyi , Gan Wenting , Jiang Hua
Published: April 2023

Supplementary FigureS4. Suggested optional approaches for the management of children with R/R-AML.
Supplemental Table S2 from Clinical and Functional Characterization of Atypical KRAS/NRAS Mutations in Metastatic Colorectal Cancer
Authors: Loree Jonathan M. , Wang Yucai , Syed Muddassir A. , Sorokin Alexey V. , Coker Oluwadara , Xiu Joanne , Weinberg Benjamin A. , Vanderwalde Ari M. , Tesfaye Anteneh , Raymond Victoria M. , Miron Benjamin , Tarcic Gabi , Zelichov Ori , Broaddus Russell R. , Ng Patrick Kwok Shing , Jeong Kang Jin , Tsang Yiu Huen , Mills Gordon B. , Overman Michael J. , Grothey Axel , Marshall John L. , Kopetz Scott
Published: April 2023

Frequency and prevalence of NRAS mutations across 8 pooled cohorts
Supplemental Table S1 from Clinical and Functional Characterization of Atypical KRAS/NRAS Mutations in Metastatic Colorectal Cancer
Authors: Loree Jonathan M. , Wang Yucai , Syed Muddassir A. , Sorokin Alexey V. , Coker Oluwadara , Xiu Joanne , Weinberg Benjamin A. , Vanderwalde Ari M. , Tesfaye Anteneh , Raymond Victoria M. , Miron Benjamin , Tarcic Gabi , Zelichov Ori , Broaddus Russell R. , Ng Patrick Kwok Shing , Jeong Kang Jin , Tsang Yiu Huen , Mills Gordon B. , Overman Michael J. , Grothey Axel , Marshall John L. , Kopetz Scott
Published: April 2023

Frequency and prevalence of KRAS mutations across 8 pooled cohorts
Table S1 from Therapeutic Implications of Detecting MAPK-Activating Alterations in Cutaneous and Unknown Primary Melanomas
Authors: Shoushtari Alexander N. , Chatila Walid K. , Arora Arshi , Sanchez-Vega Francisco , Kantheti Havish S. , Rojas Zamalloa Jorge A. , Krieger Penina , Callahan Margaret K. , Betof Warner Allison , Postow Michael A. , Momtaz Parisa , Nair Suresh , Ariyan Charlotte E. , Barker Christopher A. , Brady Mary Susan , Coit Daniel G. , Rosen Neal , Chapman Paul B. , Busam Klaus J. , Solit David B. , Panageas Katherine S. , Wolchok Jedd D. , Schultz Nikolaus
Published: April 2023

MAF file
Supplementary Data from IFNα Augments Clinical Efficacy of Regulatory T-cell Depletion with Denileukin Diftitox in Ovarian Cancer
Authors: Thibodeaux Suzanne R. , Barnett Brian B. , Pandeswara Srilakshmi , Wall Shawna R. , Hurez Vincent , Dao Vinh , Sun Lishi , Daniel Benjamin J. , Brumlik Michael J. , Drerup Justin , Padrón Álvaro , Whiteside Teresa , Kryczek Ilona , Zou Weiping , Curiel Tyler J.
Published: April 2023

Suppl. Fig. S1 DD depletes Tregs, which are characterized by CD4, CD25, and Foxp3 expression
Figure S2 from Alpha-smooth Muscle Actin Expression in the Stroma Predicts Resistance to Trastuzumab in Patients with Early-stage HER2-positive Breast Cancer
Authors: Vathiotis Ioannis A. , Moutafi Myrto K. , Divakar Prajan , Aung Thazin Nwe , Qing Tao , Fernandez Aileen , Yaghoobi Vesal , El-Abed Sarra , Wang Yingbo , Guillaume Sebastien , Nuciforo Paolo , Huober Jens , Di Cosimo Serena , Kim Sung-Bae , Harbeck Nadia , Gomez Henry , Shafi Saba , Syrigos Konstantinos N. , Fountzilas George , Sotiriou Christos , Pusztai Lajos , Warren Sarah , Rimm David L.
Published: April 2023

Scatter plots showing the correlation between different blocks of YTMA247 for HER2 (A) and Ki67 (B), both measured in the tumor compartment.
Supplementary Figure 1 from Phase I, First-in-Human Study of the Probody Therapeutic CX-2029 in Adults with Advanced Solid Tumor Malignancies
Authors: Johnson Melissa , El-Khoueiry Anthony , Hafez Navid , Lakhani Nehal , Mamdani Hirva , Rodon Jordi , Sanborn Rachel E. , Garcia-Corbacho Javier , Boni Valentina , Stroh Mark , Hannah Alison L. , Wang Song , Castro Henry , Spira Alexander
Published: April 2023

Plots of reticulocyte percentages from Cycle 1 Day 1 through Cycle 2 Day 1
Table S3 from The Landscape of Cell-Free HBV Integrations and Mutations in Cirrhosis and Hepatocellular Carcinoma Patients
Authors: Zheng Bo , Liu Xiao-Long , Fan Rong , Bai Jian , Wen Hao , Du Lu-Tao , Jiang Guo-Qing , Wang Chun-Ying , Fan Xiao-Tang , Ye Yi-Nong , Qian Yun-Song , Wang Ying-Chao , Liu Gao-Jing , Deng Guo-Hong , Shen Feng , Hu He-Ping , Wang Hui , Zhang Qing-Zheng , Ru Lan-Lan , Zhang Jing , Gao Yan-Hang , Xia Jie , Yan Hua-Dong , Liang Min-Feng , Yu Yan-Long , Sun Fu-Ming , Gao Yu-Jing , Sun Jian , Zhong Chun-Xiu , Wang Yin , Kong Fei , Chen Jin-Ming , Zheng Dan , Yang Yuan , Wang Chuan-Xin , Wu Lin , Hou Jin-Lin , Liu Jing-Feng , Wang Hong-Yang , Chen Lei
Published: April 2023

Table S3
Supplementary Data from The Landscape of Cell-Free HBV Integrations and Mutations in Cirrhosis and Hepatocellular Carcinoma Patients
Authors: Zheng Bo , Liu Xiao-Long , Fan Rong , Bai Jian , Wen Hao , Du Lu-Tao , Jiang Guo-Qing , Wang Chun-Ying , Fan Xiao-Tang , Ye Yi-Nong , Qian Yun-Song , Wang Ying-Chao , Liu Gao-Jing , Deng Guo-Hong , Shen Feng , Hu He-Ping , Wang Hui , Zhang Qing-Zheng , Ru Lan-Lan , Zhang Jing , Gao Yan-Hang , Xia Jie , Yan Hua-Dong , Liang Min-Feng , Yu Yan-Long , Sun Fu-Ming , Gao Yu-Jing , Sun Jian , Zhong Chun-Xiu , Wang Yin , Kong Fei , Chen Jin-Ming , Zheng Dan , Yang Yuan , Wang Chuan-Xin , Wu Lin , Hou Jin-Lin , Liu Jing-Feng , Wang Hong-Yang , Chen Lei
Published: April 2023

Supplementary figures
Supplementary Tables from First-Line Afatinib plus Cetuximab for EGFR-Mutant Non–Small Cell Lung Cancer: Results from the Randomized Phase II IFCT-1503 ACE-Lung Study
Authors: Cortot Alexis B. , Madroszyk Anne , Giroux-Leprieur Etienne , Molinier Olivier , Quoix Elisabeth , Bérard Henri , Otto Josiane , Rault Isabelle , Moro-Sibilot Denis , Raimbourg Judith , Amour Elodie , Morin Franck , Hureaux José , Moreau Lionel , Debieuvre Didier , Morel Hugues , Renault Aldo , Pichon Eric , Huret Benjamin , Charpentier Sandrine , Denis Marc G. , Cadranel Jacques
Published: April 2023

Supplementary Tables
Supplementary Table from Phase I/II Trial of Exemestane, Ribociclib, and Everolimus in Women with HR+/HER2− Advanced Breast Cancer after Progression on CDK4/6 Inhibitors (TRINITI-1)
Authors: Bardia Aditya , Hurvitz Sara A. , DeMichele Angela , Clark Amy S. , Zelnak Amelia , Yardley Denise A. , Karuturi Meghan , Sanft Tara , Blau Sibel , Hart Lowell , Ma Cynthia , Rugo Hope S. , Purkayastha Das , Moulder Stacy
Published: April 2023

Supplementary Tables
Supplementary Figure S2 from Integrated Human and Murine Clinical Study Establishes Clinical Efficacy of Ruxolitinib in Chronic Myelomonocytic Leukemia
Authors: Hunter Anthony M. , Newman Hannah , Dezern Amy E. , Steensma David P. , Niyongere Sandrine , Roboz Gail J. , Mo Qianxing , Chan Onyee , Gerds Aaron , Sallman David A. , Dominguez-Viqueira William , Letson Christopher , Balasis Maria E. , Ball Markus , Kruer Traci , Zhang Hailing , Lancet Jeffrey E. , List Alan F. , Sekeres Mikkael A. , Komrokji Rami S. , Padron Eric
Published: April 2023

Supplementary Figure S2 depicts the change in symptom scores between baseline and day 30 of treatment, stratified by response to therapy.
Supplementary Figure 8 from Yap1 Mediates Trametinib Resistance in Head and Neck Squamous Cell Carcinomas
Authors: Mudianto Tenny , Campbell Katie M. , Webb Jason , Zolkind Paul , Skidmore Zachary L. , Riley Rachel , Barnell Erica K. , Ozgenc Ibrahim , Giri Tusar , Dunn Gavin P. , Adkins Douglas R. , Griffith Malachi , Egloff Ann Marie , Griffith Obi L. , Uppaluri Ravindra
Published: April 2023

Supplementary Figure 8
Supplementary Data from A Phase I Study of Alpelisib in Combination with Trastuzumab and LJM716 in Patients with PIK3CA-Mutated HER2-Positive Metastatic Breast Cancer
Authors: Jhaveri Komal , Drago Joshua Z. , Shah Payal Deepak , Wang Rui , Pareja Fresia , Ratzon Fanni , Iasonos Alexia , Patil Sujata , Rosen Neal , Fornier Monica N. , Sklarin Nancy T. , Chandarlapaty Sarat , Modi Shanu
Published: April 2023

Supplementary Methods
Supplementary Data from Yap1 Mediates Trametinib Resistance in Head and Neck Squamous Cell Carcinomas
Authors: Mudianto Tenny , Campbell Katie M. , Webb Jason , Zolkind Paul , Skidmore Zachary L. , Riley Rachel , Barnell Erica K. , Ozgenc Ibrahim , Giri Tusar , Dunn Gavin P. , Adkins Douglas R. , Griffith Malachi , Egloff Ann Marie , Griffith Obi L. , Uppaluri Ravindra
Published: April 2023

Supplementary Legends and Methods
Supplementary Table 3 from The Chronic Lymphocytic Leukemia Comorbidity Index (CLL-CI): A Three-Factor Comorbidity Model
Authors: Gordon Max J. , Kaempf Andy , Sitlinger Andrea , Shouse Geoffrey , Mei Matthew , Brander Danielle M. , Salous Tareq , Hill Brian T. , Alqahtani Hamood , Choi Michael , Churnetski Michael C. , Cohen Jonathon B. , Stephens Deborah M. , Siddiqi Tanya , Rivera Xavier , Persky Daniel , Wisniewski Paul , Patel Krish , Shadman Mazyar , Park Byung , Danilov Alexey V.
Published: April 2023

S Table 3
Table S2 from Regulation of OATP1B1 Function by Tyrosine Kinase–mediated Phosphorylation
Authors: Hayden Elizabeth R. , Chen Mingqing , Pasquariello Kyle Z. , Gibson Alice A. , Petti James J. , Shen Shichen , Qu Jun , Ong Su Sien , Chen Taosheng , Jin Yan , Uddin Muhammad Erfan , Huang Kevin M. , Paz Aviv , Sparreboom Alex , Hu Shuiying , Sprowl Jason A.
Published: April 2023

Cellular viability and uptake of 8FcA by OATP1B1 following reverse transfection with 25 nM siRNA for various protein kinases. Percent uptake was determined relative to OATP1B1 uptake with control siRNA.
Study protocol and SAP from Adjuvant Low-dose Statin Use after Radical Prostatectomy: The PRO-STAT Randomized Clinical Trial
Authors: Jeong In Gab , Lim Bumjin , Yun Sung-Cheol , Lim Ju Hyun , Hong Jun Hyuk , Kim Choung-Soo
Published: April 2023

Study protocol and SAP
Table S1 from Sulindac, a Nonselective NSAID, Reduces Breast Density in Postmenopausal Women with Breast Cancer Treated with Aromatase Inhibitors
Authors: Thompson Patricia A. , Huang Chuan , Yang Jie , Wertheim Betsy C. , Roe Denise , Zhang Xiaoyue , Ding Jie , Chalasani Pavani , Preece Christina , Martinez Jessica , Chow H.-H. Sherry , Stopeck Alison T.
Published: April 2023

Table presenting estimates of relative change in MRPD at 6 and 12 months in each group with additional adjustments.
Supplementary Tables from Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer
Authors: Parikh Aparna R. , Van Seventer Emily E. , Siravegna Giulia , Hartwig Anna V. , Jaimovich Ariel , He Yupeng , Kanter Katie , Fish Madeleine G. , Fosbenner Kathryn D. , Miao Benchun , Phillips Susannah , Carmichael John H. , Sharma Nihaarika , Jarnagin Joy , Baiev Islam , Shah Yojan S. , Fetter Isobel J. , Shahzade Heather A. , Allen Jill N. , Blaszkowsky Lawrence S. , Clark Jeffrey W. , Dubois Jon S. , Franses Joseph W. , Giantonio Bruce J. , Goyal Lipika , Klempner Samuel J. , Nipp Ryan D. , Roeland Eric J. , Ryan David P. , Weekes Colin D. , Wo Jennifer Y. , Hong Theodore S. , Bordeianou Liliana , Ferrone Cristina R. , Qadan Motaz , Kunitake Hiroko , Berger David , Ricciardi Rocco , Cusack James C. , Raymond Victoria M. , Talasaz AmirAli , Boland Genevieve M. , Corcoran Ryan B.
Published: April 2023

Supplementary Tables
Figure S7. from Fecal Microbiota Transplantation from Overweight or Obese Donors in Cachectic Patients with Advanced Gastroesophageal Cancer: A Randomized, Double-blind, Placebo-Controlled, Phase II Study
Authors: de Clercq Nicolien C. , van den Ende Tom , Prodan Andrei , Hemke Robert , Davids Mark , Pedersen Helle K. , Nielsen Henrik B. , Groen A.K. , de Vos Willem M. , van Laarhoven Hanneke W.M. , Nieuwdorp Max
Published: April 2023

Microbial phyla plots
Supplementary Data from TP53 Mutations with Low Variant Allele Frequency Predict Short Survival in Chronic Lymphocytic Leukemia
Authors: Bomben Riccardo , Rossi Francesca Maria , Vit Filippo , Bittolo Tamara , D'Agaro Tiziana , Zucchetto Antonella , Tissino Erika , Pozzo Federico , Vendramini Elena , Degan Massimo , Zaina Eva , Cattarossi Ilaria , Varaschin Paola , Nanni Paola , Berton Michele , Braida Alessandra , Polesel Jerry , Cohen Jared A. , Santinelli Enrico , Biagi Annalisa , Gentile Massimo , Morabito Fortunato , Fronza Gilberto , Pozzato Gabriele , D'Arena Giovanni , Olivieri Jacopo , Bulian Pietro , Pepper Chris , Hockaday Anna , Schuh Anna , Hillmen Peter , Rossi Davide , Chiarenza Annalisa , Zaja Francesco , Di Raimondo Francesco , Del Poeta Giovanni , Gattei Valter
Published: April 2023

Supplemental Material and Methods
Table.S2-S5 from Genome-Wide miRNA Expression Profiling of Molecular Subgroups of Peripheral T-cell Lymphoma
Authors: Lone Waseem , Bouska Alyssa , Sharma Sunandini , Amador Catalina , Saumyaranjan Mallick , Herek Tyler A. , Heavican Tayla B. , Yu Jiayu , Lim Soon Thye , Ong Choon Kiat , Slack Graham W. , Savage Kerry J. , Rosenwald Andreas , Ott German , Cook James R. , Feldman Andrew L. , Rimsza Lisa M. , McKeithan Timothy W. , Greiner Timothy C. , Weisenburger Dennis D. , Melle Federica , Motta Giovanna , Pileri Stefano , Vose Julie M. , Chan Wing C. , Iqbal Javeed
Published: April 2023

Table S2: List of Antibodies used for the Western Blot Table S3: List of flow cytometry Antibodies used for the expression of different markers Table S4: List of genes and their Forward and Reverse Sequence for the evaluation of mRNA expression by performing Real time RT PCR Table S5: Mature Sequence of miR-126-3p and miR-145-5p taqman Probe used for Taqman base Real time qPCR assay
Figure.S6 from Genome-Wide miRNA Expression Profiling of Molecular Subgroups of Peripheral T-cell Lymphoma
Authors: Lone Waseem , Bouska Alyssa , Sharma Sunandini , Amador Catalina , Saumyaranjan Mallick , Herek Tyler A. , Heavican Tayla B. , Yu Jiayu , Lim Soon Thye , Ong Choon Kiat , Slack Graham W. , Savage Kerry J. , Rosenwald Andreas , Ott German , Cook James R. , Feldman Andrew L. , Rimsza Lisa M. , McKeithan Timothy W. , Greiner Timothy C. , Weisenburger Dennis D. , Melle Federica , Motta Giovanna , Pileri Stefano , Vose Julie M. , Chan Wing C. , Iqbal Javeed
Published: April 2023

Figure S6: Overall Survival in PTCL by miRNA expression. Kaplan-Meier curve representing overall survival of PTCL-NOS cases (n=24) by higher vs lower expression of miR-29c (A) and miR-106 (B) expression. (C) Correlation of n-Counter values between miR-126 and miR-145 expression (r=0.1)
Supplementary Data from Immunotherapy-Mediated Thyroid Dysfunction: Genetic Risk and Impact on Outcomes with PD-1 Blockade in Non–Small Cell Lung Cancer
Authors: Luo Jia , Martucci Victoria L. , Quandt Zoe , Groha Stefan , Murray Megan H. , Lovly Christine M. , Rizvi Hira , Egger Jacklynn V. , Plodkowski Andrew J. , Abu-Akeel Mohsen , Schulze Isabell , Merghoub Taha , Cardenas Eduardo , Huntsman Scott , Li Min , Hu Donglei , Gubens Matthew A. , Gusev Alexander , Aldrich Melinda C. , Hellmann Matthew D. , Ziv Elad
Published: April 2023

Supplementary Index F1-F7 and T1-T2
Table S4 from Structural Variants at the BRCA1/2 Loci are a Common Source of Homologous Repair Deficiency in High-grade Serous Ovarian Carcinoma
Authors: Ewing Ailith , Meynert Alison , Churchman Michael , Grimes Graeme R. , Hollis Robert L. , Herrington C. Simon , Rye Tzyvia , Bartos Clare , Croy Ian , Ferguson Michelle , Lennie Mairi , McGoldrick Trevor , McPhail Neil , Siddiqui Nadeem , Dowson Suzanne , Glasspool Rosalind , Mackean Melanie , Nussey Fiona , McDade Brian , Ennis Darren , McMahon Lynn , Matakidou Athena , Dougherty Brian , March Ruth , Barrett J. Carl , McNeish Iain A. , Biankin Andrew V. , Roxburgh Patricia , Gourley Charlie , Semple Colin A.
Published: April 2023

Differentially expressed genes in HR deficiency
Supplementary Table 4 from Phase I Study of MEDI3726: A Prostate-Specific Membrane Antigen-Targeted Antibody–Drug Conjugate, in Patients with mCRPC after Failure of Abiraterone or Enzalutamide
Authors: de Bono Johann S. , Fleming Mark T. , Wang Judy S. , Cathomas Richard , Miralles Manuel Selvi , Bothos John , Hinrichs Mary Jane , Zhang Qu , He Peng , Williams Marna , Rosenbaum Anton I. , Liang Meina , Vashisht Kapil , Cho Song , Martinez Pablo , Petrylak Daniel P.
Published: April 2023

Per-patient ADA responses
Supplementary Data from Safety, Antitumor Activity, and Biomarker Analysis in a Phase I Trial of the Once-daily Wee1 Inhibitor Adavosertib (AZD1775) in Patients with Advanced Solid Tumors
Authors: Takebe Naoko , Naqash Abdul Rafeh , O'Sullivan Coyne Geraldine , Kummar Shivaani , Do Khanh , Bruns Ashley , Juwara Lamin , Zlott Jennifer , Rubinstein Larry , Piekarz Richard , Sharon Elad , Streicher Howard , Mittra Arjun , Miller Sarah B. , Ji Jiuping , Wilsker Deborah , Kinders Robert J. , Parchment Ralph E. , Chen Li , Chang Ting-Chia , Das Biswajit , Mugundu Ganesh , Doroshow James H. , Chen Alice P.
Published: April 2023

Supplementary Methods, Supplementary Fig. S1 (Mean adavosertib plasma concentrations for QD vs. BID schedules), Supplementary Fig. S2 (Example PD biomarker immunofluorescence images), Supplementary Fig. S3 (CCNE1 tumor alteration frequency IMPACT data), Supplementary Fig. S4 (Independence of tumor CCNE1 mRNA expression and CCNE1 CNA in TCGA ovarian and endometrial cohorts), Supplementary Table S1 (DLTs), Supplementary Table S2 (Non-DLT dose reductions), Supplementary Table S3 (Responses and baseline genomic characteristics for patients with ovarian carcinoma and prior PARP inhibitor therapy), Supplementary Table S4 (Mean Cycle 1 Day 1 PK parameters), Supplementary Table S5 (Patient tumor mutations identified by WES), Supplementary References
Supplementary Data from Lutetium-177-PSMA-617 in Low-Volume Hormone-Sensitive Metastatic Prostate Cancer: A Prospective Pilot Study
Authors: Privé Bastiaan M. , Peters Steffie M.B. , Muselaers Constantijn H.J. , van Oort Inge M. , Janssen Marcel J.R. , Sedelaar J.P. Michiel , Konijnenberg Mark W. , Zámecnik Patrik , Uijen Maike J.M. , Schilham Melline G.M. , Eek Annemarie , Scheenen Tom W.J. , Verzijlbergen J. Fred , Gerritsen Winald R. , Mehra Niven , Kerkmeijer Linda G.W. , Smeenk Robert J. , Somford Diederik M. , van Basten Jean-Paul A. , Heskamp Sandra , Barentsz Jelle O. , Gotthardt Martin , Witjes J. Alfred , Nagarajah James
Published: April 2023

Supplementary Data
Figure S3 from A Blood-based Assay for Assessment of Tumor Mutational Burden in First-line Metastatic NSCLC Treatment: Results from the MYSTIC Study
Authors: Si Han , Kuziora Michael , Quinn Katie J. , Helman Elena , Ye Jiabu , Liu Feng , Scheuring Urban , Peters Solange , Rizvi Naiyer A. , Brohawn Philip Z. , Ranade Koustubh , Higgs Brandon W. , Banks Kimberly C. , Chand Vikram K. , Raja Rajiv
Published: April 2023

Analytical validation of the GuardantOMNI bTMB assay
Supplementary Figure S5 from Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood–Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies
Authors: Kerbauy Lucila N. , Marin Nancy D. , Kaplan Mecit , Banerjee Pinaki P. , Berrien-Elliott Melissa M. , Becker-Hapak Michelle , Basar Rafet , Foster Mark , Garcia Melo Luciana , Neal Carly C. , McClain Ethan , Daher May , Nunez Cortes Ana Karen , Desai Sweta , Inng Lim Francesca Wei , Mendt Mayela Carolina , Schappe Timothy , Li Li , Shaim Hila , Shanley Mayra , Ensley Emily L. , Uprety Nadima , Wong Pamela , Liu Enli , Ang Sonny O. , Cai Rong , Nandivada Vandana , Mohanty Vakul , Miao Qi , Shen Yifei , Baran Natalia , Fowlkes Natalie W. , Chen Ken , Muniz-Feliciano Luis , Champlin Richard E. , Nieto Yago L. , Koch Joachim , Treder Martin , Fischer Wolfgang , Okamoto Oswaldo Keith , Shpall Elizabeth J. , Fehniger Todd A. , Rezvani Katayoun
Published: April 2023

Supplementary Fig. S5. CD16 expression on pre-activated and expanded CB-NK cells.
Supplementary Data from Molecular Characterization and Therapeutic Targeting of Colorectal Cancers Harboring Receptor Tyrosine Kinase Fusions
Authors: Singh Harshabad , Li Yvonne Y. , Spurr Liam F. , Shinagare Atul B. , Abhyankar Ritika , Reilly Emma , Brais Lauren K. , Nag Anwesha , Ducar Matthew D. , Thorner Aaron R. , Shapiro Geoffrey I. , Keller Rachel B. , Siletti Cheta , Clark Jeffrey W. , Farago Anna F. , Lin Jessica J. , Demetri George D. , Gujrathi Rahul , Kulke Matthew H. , MacConaill Laura E. , Ligon Azra H. , Sicinska Ewa , Meyerson Matthew L. , Meyerhardt Jeffrey A. , Cherniack Andrew D. , Wolpin Brian M. , Ng Kimmie , Giannakis Marios , Hornick Jason L. , Cleary James M.
Published: April 2023

Supplementary Figure 1. Pan-TRK IHC in four cases identified as having NTRK fusions by OncoPanel analysis shows strong cytoplasmic staining confirming the presence of functional TRK fusion protein (40Ã-). Top left image demonstrates the specificity of TRK staining, which is present only in neoplastic cells, whereas adjacent normal crypts are negative. Supplementary Figure 2A. Two cases of ALK fusion in our cohort shared clinical and molecular features but differed in their microsatellite status. Both tumors were APC wild-type (wt) and contained biallelic RNF43 frameshift (fs) mutations. B. Copy number variation by chromosome is color-coded for two ALK fusion-associated colon cancers in our cohort. ALK+MMR-D cancer (top) displays a diploid genome, whereas ALK+MSS cancer (bottom) displays frequent copy number gains and losses. ALK fusion breakpoints are shown in both profiles (arrow). The vertical axis is the ratio of the number of reads for each specimen and a panel of normals in log base 2 scale. A value of 0 denotes no difference from normal (diploid). Supplementary Figure 3A. MMR-D RTK fusion CRC cases display a diploid genome similar to those in other MMR-D cases: BRAF V600E+mutated and Lynch syndrome. Copy number profile plots of RTK fusions or Wnt fusions with MSS CRC show extensive gains and losses and are shown for comparison. 3B. All MMR-D subgroups: BRAF V600E+, Lynch syndrome and RTK fusion show a significantly higher homopolymer indel rate (top) and TMB (bottom) than do MSS tumors with either RTK fusions or Wnt fusions. Supplementary Figure. 4. Histologic analysis with hematoxylin and eosin stained slides for two patients with NTRK1-LMNA fusions. Morphological analysis shows: A. mucinous and B. medullary histology.
Figure S2 from Changes in Diffuse Optical Tomography Images During Early Stages of Neoadjuvant Chemotherapy Correlate with Tumor Response in Different Breast Cancer Subtypes
Authors: Altoe Mirella L. , Kalinsky Kevin , Marone Alessandro , Kim Hyun K. , Guo Hua , Hibshoosh Hanina , Tejada Mariella , Crew Katherine D. , Accordino Melissa K. , Trivedi Meghna S. , Hershman Dawn L. , Hielscher Andreas H.
Published: April 2023

A linear regression fitting indicates a moderate positive correlation between baseline ã€-â^†_TP1 ctHHbã€-_N and RCB scores (r = .448, p < 0.0005). Tumors above the dashed line (ã€-â^†_TP1 ctHHbã€-_N = 1) experienced an increase in ã€-ctHHbã€-_N levels at TP1, after 2 -3 taxane cycles. Confidence interval is displayed around smooth.
Supplementary Data from Immune Activation and Microbial Translocation as Prognostic Biomarkers for AIDS-Related Non-Hodgkin Lymphoma in the AMC-034 Study
Authors: Martínez Laura E. , Lensing Shelly , Chang Di , Magpantay Larry I. , Mitsuyasu Ronald , Ambinder Richard F. , Sparano Joseph A. , Martínez-Maza Otoniel , Epeldegui Marta
Published: April 2023

Figure S1
Supplementary Data from Combined EZH2 Inhibition and IKAROS Degradation Leads to Enhanced Antitumor Activity in Diffuse Large B-cell Lymphoma
Authors: Tong Kit I. , Yoon Sharon , Isaev Keren , Bakhtiari Mehran , Lackraj Tracy , He Michael Y. , Joynt Jesse , Silva Anjali , Xu Maria C. , Privé Gilbert G. , He Housheng Hansen , Tiedemann Rodger E. , Chavez Elizabeth A. , Chong Lauren C. , Boyle Merrill , Scott David W. , Steidl Christian , Kridel Robert
Published: April 2023

Supplementary Data
Table S2 from Camrelizumab plus Famitinib in Patients with Advanced or Metastatic Renal Cell Carcinoma: Data from an Open-label, Multicenter Phase II Basket Study
Authors: Qu Yuan-Yuan , Zhang Hai-Liang , Guo Hongqian , Luo Hong , Zou Qing , Xing Nianzeng , Xia Shujie , Sun Zhongquan , Zhang Xuepei , He Chaohong , Cai Jinling , Zhang Xiao , Wang Quanren , Ye Ding-Wei
Published: April 2023

Treatment-related adverse events leading to dose modification
Supplementary Table 1 from PGC1α-Mediated Metabolic Reprogramming Drives the Stemness of Pancreatic Precursor Lesions
Authors: Nimmakayala Rama Krishna , Rauth Sanchita , Chirravuri Venkata Ramakanth , Marimuthu Saravanakumar , Nallasamy Palanisamy , Vengoji Raghupathy , Lele Subodh M. , Rachagani Satyanarayana , Mallya Kavita , Malafa Mokenge P. , Ponnusamy Moorthy P. , Batra Surinder K.
Published: April 2023

qRT-PCR primers used in this study
Supplementary Figure 2 from PGC1α-Mediated Metabolic Reprogramming Drives the Stemness of Pancreatic Precursor Lesions
Authors: Nimmakayala Rama Krishna , Rauth Sanchita , Chirravuri Venkata Ramakanth , Marimuthu Saravanakumar , Nallasamy Palanisamy , Vengoji Raghupathy , Lele Subodh M. , Rachagani Satyanarayana , Mallya Kavita , Malafa Mokenge P. , Ponnusamy Moorthy P. , Batra Surinder K.
Published: April 2023

Morphology of mouse primary acinar cells in culture.
Supplementary Data S1 from First-in-Human Phase 1 Study of MORAb-202, an Antibody–Drug Conjugate Comprising Farletuzumab Linked to Eribulin Mesylate, in Patients with Folate Receptor-α–Positive Advanced Solid Tumors
Authors: Shimizu Toshio , Fujiwara Yutaka , Yonemori Kan , Koyama Takafumi , Sato Jun , Tamura Kenji , Shimomura Akihiko , Ikezawa Hiroki , Nomoto Maiko , Furuuchi Keiji , Nakajima Ryo , Miura Takuma , Yamamoto Noboru
Published: April 2023

Supplementary Data S1 from First-in-Human Phase 1 Study of MORAb-202, an Antibody–Drug Conjugate Comprising Farletuzumab Linked to Eribulin Mesylate, in Patients with Folate Receptor-α–Positive Advanced Solid Tumors
Table S2 from Optimized EGFR Blockade Strategies in EGFR Addicted Gastroesophageal Adenocarcinomas
Authors: Corso Simona , Pietrantonio Filippo , Apicella Maria , Migliore Cristina , Conticelli Daniela , Petrelli Annalisa , D'Errico Laura , Durando Stefania , Moya-Rull Daniel , Bellomo Sara E. , Ughetto Stefano , Degiuli Maurizio , Reddavid Rossella , Fumagalli Uberto , De Pascale Stefano , Sgroi Giovanni , Rausa Emanuele , Baiocchi Gian Luca , Molfino Sarah , De Manzoni Giovanni , Bencivenga Maria , Siena Salvatore , Sartore-Bianchi Andrea , Morano Federica , Corallo Salvatore , Prisciandaro Michele , Di Bartolomeo Maria , Gloghini Annunziata , Marsoni Silvia , Sottile Antonino , Sapino Anna , Marchiò Caterina , Dahle-Smith Asa , Miedzybrodzka Zosia , Lee Jessica , Ali Siraj M. , Ross Jeffrey S. , Alexander Brian M. , Miller Vincent A. , Petty Russell , Schrock Alexa B. , Giordano Silvia
Published: April 2023

Supplementary Table 2
Supplementary Figure 10 from PGC1α-Mediated Metabolic Reprogramming Drives the Stemness of Pancreatic Precursor Lesions
Authors: Nimmakayala Rama Krishna , Rauth Sanchita , Chirravuri Venkata Ramakanth , Marimuthu Saravanakumar , Nallasamy Palanisamy , Vengoji Raghupathy , Lele Subodh M. , Rachagani Satyanarayana , Mallya Kavita , Malafa Mokenge P. , Ponnusamy Moorthy P. , Batra Surinder K.
Published: April 2023

Analysis of FAO-OCR using extracellular flux analyzer and Seahorse XF-Palmitate-BSA FAO substrate kit in KC6141 (KC control) cells in the presence and absence of doxycycline.
Figure S3 from Optimized EGFR Blockade Strategies in EGFR Addicted Gastroesophageal Adenocarcinomas
Authors: Corso Simona , Pietrantonio Filippo , Apicella Maria , Migliore Cristina , Conticelli Daniela , Petrelli Annalisa , D'Errico Laura , Durando Stefania , Moya-Rull Daniel , Bellomo Sara E. , Ughetto Stefano , Degiuli Maurizio , Reddavid Rossella , Fumagalli Uberto , De Pascale Stefano , Sgroi Giovanni , Rausa Emanuele , Baiocchi Gian Luca , Molfino Sarah , De Manzoni Giovanni , Bencivenga Maria , Siena Salvatore , Sartore-Bianchi Andrea , Morano Federica , Corallo Salvatore , Prisciandaro Michele , Di Bartolomeo Maria , Gloghini Annunziata , Marsoni Silvia , Sottile Antonino , Sapino Anna , Marchiò Caterina , Dahle-Smith Asa , Miedzybrodzka Zosia , Lee Jessica , Ali Siraj M. , Ross Jeffrey S. , Alexander Brian M. , Miller Vincent A. , Petty Russell , Schrock Alexa B. , Giordano Silvia
Published: April 2023

Supplementary Figure 3
Table S1 from Impact of Prior Treatment on the Efficacy of Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma
Authors: Seitter Samantha J. , Sherry Richard M. , Yang James C. , Robbins Paul F. , Shindorf Mackenzie L. , Copeland Amy R. , McGowan Christine T. , Epstein Monica , Shelton Thomas E. , Langhan Michelle M. , Franco Zulmarie , Danforth David N. , White Donald E. , Rosenberg Steven A. , Goff Stephanie L.
Published: April 2023

Table S1 describes patient characteristics by clinical response to treatment
Supplementary Data from Heterogeneity of IFN-Mediated Responses and Tumor Immunogenicity in Patients with Cervical Cancer Receiving Concurrent Chemoradiotherapy
Authors: Chen Jianzhou , Chen Chuangzhen , Zhan Yizhou , Zhou Li , Chen Jie , Cai Qingxin , Wu Yanxuan , Sui Zhihan , Zeng Chengbing , Wei Xiaolong , Muschel Ruth
Published: April 2023

Table S1-S7
Tables S1 - S10 from Evolution of Castration-Resistant Prostate Cancer in ctDNA during Sequential Androgen Receptor Pathway Inhibition
Authors: Annala Matti , Taavitsainen Sinja , Khalaf Daniel J. , Vandekerkhove Gillian , Beja Kevin , Sipola Joonatan , Warner Evan W. , Herberts Cameron , Wong Amanda , Fu Simon , Finch Daygen L. , Oja Conrad D. , Vergidis Joanna , Zulfiqar Muhammad , Eigl Bernhard J. , Kollmansberger Christian K. , Nykter Matti , Gleave Martin E. , Chi Kim N. , Wyatt Alexander W.
Published: April 2023

An excel file containing Supplementary Tables S1 - S10
Supplementary Figure S19 from Evolution of Castration-Resistant Prostate Cancer in ctDNA during Sequential Androgen Receptor Pathway Inhibition
Authors: Annala Matti , Taavitsainen Sinja , Khalaf Daniel J. , Vandekerkhove Gillian , Beja Kevin , Sipola Joonatan , Warner Evan W. , Herberts Cameron , Wong Amanda , Fu Simon , Finch Daygen L. , Oja Conrad D. , Vergidis Joanna , Zulfiqar Muhammad , Eigl Bernhard J. , Kollmansberger Christian K. , Nykter Matti , Gleave Martin E. , Chi Kim N. , Wyatt Alexander W.
Published: April 2023

Supplementary Figure S19 shows the complete switch of circulating tumor DNA profile in patient 026 between baseline and first progression timepoints
Supplementary Figure S15 from Evolution of Castration-Resistant Prostate Cancer in ctDNA during Sequential Androgen Receptor Pathway Inhibition
Authors: Annala Matti , Taavitsainen Sinja , Khalaf Daniel J. , Vandekerkhove Gillian , Beja Kevin , Sipola Joonatan , Warner Evan W. , Herberts Cameron , Wong Amanda , Fu Simon , Finch Daygen L. , Oja Conrad D. , Vergidis Joanna , Zulfiqar Muhammad , Eigl Bernhard J. , Kollmansberger Christian K. , Nykter Matti , Gleave Martin E. , Chi Kim N. , Wyatt Alexander W.
Published: April 2023

Supplementary Figure S15 shows temporal changes in whole exome copy number profile in patients that had evidence for copy number profile change in 72-gene targeted sequencing